Privia Health Group (NASDAQ:PRVA) Price Target Raised to $27.00 at Truist Financial

Privia Health Group (NASDAQ:PRVA - Free Report) had its price target raised by Truist Financial from $24.00 to $27.00 in a research report sent to investors on Friday,Benzinga reports. Truist Financial currently has a buy rating on the stock.

PRVA has been the topic of several other research reports. KeyCorp started coverage on Privia Health Group in a report on Friday, October 11th. They set an "overweight" rating and a $23.00 price objective on the stock. Royal Bank of Canada restated an "outperform" rating and issued a $28.00 price target on shares of Privia Health Group in a report on Wednesday, August 14th. Finally, Robert W. Baird upped their price objective on shares of Privia Health Group from $23.00 to $24.00 and gave the company an "outperform" rating in a research note on Monday, August 26th. Two investment analysts have rated the stock with a hold rating, twelve have given a buy rating and two have assigned a strong buy rating to the company's stock. According to data from MarketBeat, the stock has an average rating of "Buy" and an average price target of $25.07.

Privia Health Group Stock Performance

PRVA stock traded down $1.23 on Friday, reaching $21.30. The company had a trading volume of 1,626,114 shares, compared to its average volume of 870,336. The company's fifty day moving average is $18.41 and its 200 day moving average is $18.34. The company has a market cap of $2.55 billion, a P/E ratio of 180.35, a PEG ratio of 4.80 and a beta of 0.76. Privia Health Group has a 1 year low of $15.92 and a 1 year high of $24.35.

Privia Health Group (NASDAQ:PRVA - Get Free Report) last released its earnings results on Thursday, August 8th. The company reported $0.03 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.05 by ($0.02). The firm had revenue of $422.30 million during the quarter, compared to analysts' expectations of $411.50 million. Privia Health Group had a net margin of 0.88% and a return on equity of 2.42%. Privia Health Group's revenue for the quarter was up 2.2% on a year-over-year basis. During the same quarter last year, the company posted $0.06 earnings per share. On average, sell-side analysts predict that Privia Health Group will post 0.17 earnings per share for the current year.

Insider Activity

In other news, CEO Parth Mehrotra sold 135,142 shares of the company's stock in a transaction on Tuesday, September 10th. The shares were sold at an average price of $18.50, for a total value of $2,500,127.00. Following the completion of the transaction, the chief executive officer now directly owns 247,771 shares in the company, valued at approximately $4,583,763.50. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Insiders own 14.20% of the company's stock.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently bought and sold shares of the business. KBC Group NV raised its position in shares of Privia Health Group by 34.6% in the 3rd quarter. KBC Group NV now owns 3,385 shares of the company's stock valued at $62,000 after purchasing an additional 871 shares in the last quarter. MQS Management LLC acquired a new stake in Privia Health Group in the third quarter valued at $217,000. Victory Capital Management Inc. grew its holdings in Privia Health Group by 402.9% during the 3rd quarter. Victory Capital Management Inc. now owns 179,049 shares of the company's stock worth $3,260,000 after acquiring an additional 143,446 shares in the last quarter. GSA Capital Partners LLP increased its position in shares of Privia Health Group by 228.1% in the 3rd quarter. GSA Capital Partners LLP now owns 50,975 shares of the company's stock worth $928,000 after purchasing an additional 35,439 shares during the last quarter. Finally, Olympiad Research LP acquired a new stake in shares of Privia Health Group in the 3rd quarter valued at about $195,000. Hedge funds and other institutional investors own 94.48% of the company's stock.

Privia Health Group Company Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.